Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 48,651 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 0.30 | Mínimo Máximo |
|||||
| Minimo del Dia | 0.2737 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Qualigen Therapeutics Inc | QLGN | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.0097 | 3.34% | 0.30 | 10:40:47 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.2914 | 0.2737 | 0.30 | 0.2903 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 69 | 48,651 | US$ 0.2780335 | US$ 13,527 | - | 0.27 - 1.26 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 10:39:06 | 100 | US$ 0.30 | USD |
Información Financiera Qualigen Therapeutics Inc QLGN
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 2.33M | 5.18M | - | 0 | -13.42M | -2.59 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Qualigen Therapeutics Inc QLGN
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 16/4/2024 | 06:00 | GlobeNewswire Inc. | Marizyme Enters Into Co-Development Agreement With Qualigen.. |
| 10/4/2024 | 07:00 | GlobeNewswire Inc. | Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors.. |
| 09/4/2024 | 07:00 | GlobeNewswire Inc. | Qualigen Therapeutics Announces Poster Featuring Positive.. |
| 27/2/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/2/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/12/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/11/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14/11/2023 | 15:30 | GlobeNewswire Inc. | Qualigen Therapeutics Provides Corporate Update for Third.. |
| 08/11/2023 | 13:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/11/2023 | 07:30 | GlobeNewswire Inc. | Qualigen Therapeutics Announces First Patient Dosed in the.. |
| 23/10/2023 | 07:30 | GlobeNewswire Inc. | Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor.. |
| 17/10/2023 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos QLGN
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.30 | 0.33 | 0.27 | 0.2947186 | 33,596 | 0.00 | 0.00% |
| 1 Month | 0.3869 | 0.407 | 0.27 | 0.334871 | 56,567 | -0.0869 | -22.46% |
| 3 Months | 0.49 | 0.5853 | 0.27 | 0.4053296 | 71,015 | -0.19 | -38.78% |
| 6 Months | 0.72 | 0.7826 | 0.27 | 0.4557438 | 47,899 | -0.42 | -58.33% |
| 1 Year | 1.02 | 1.26 | 0.27 | 0.6423249 | 34,959 | -0.72 | -70.59% |
| 3 Years | 21.20 | 31.20 | 0.27 | 15.98 | 984,724 | -20.90 | -98.58% |
| 5 Years | 72.50 | 79.00 | 0.27 | 24.68 | 1,110,914 | -72.20 | -99.59% |
